Literature DB >> 3812312

Coronary arterial abnormalities in pulmonary atresia with intact ventricular septum.

A L Calder, E E Co, M D Sage.   

Abstract

The incidence and severity of abnormalities of the coronary arteries were evaluated in 35 necropsy patients with pulmonary atresia and an intact ventricular septum. Right ventricular to coronary artery fistulous connections were found in more than 60% of the cases. All patients with fistulous connections had histologic abnormalities of the coronary arteries. In 50% the lesions were mild, with medial and intimal thickening producing up to moderate luminal stenosis. In 50% there was loss of normal arterial wall structure and severe narrowing or obliteration of the arterial lumen. The coronary arterial fistulas and histologic abnormalities were prevalent in those with underdevelopment of the tricuspid valve and right ventricular cavity but were not found in patients with a normal or dilated tricuspid valve anulus. The coronary arterial abnormalities were found in more than 80% of patients with a tricuspid valve/mitral valve ratio less than 1. A single coronary artery occurred in 6 patients (17%) of this series. In 80% of those with 1 coronary artery arising from the other, the aberrantly arising coronary artery crossed anteriorly to the pulmonary artery and could be at risk in surgical attempts to reconstruct the right ventricular outflow. Aortography is recommended if the coronary arteries are not clearly delineated on ventricular cineangiocardiography.

Entities:  

Mesh:

Year:  1987        PMID: 3812312     DOI: 10.1016/0002-9149(87)90952-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Biventricular repair versus uni-ventricular repair for pulmonary atresia with intact ventrical septum: A systematic review.

Authors:  Fei-Fei Li; Xin-Ling Du; Shu Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

Review 2.  Congenital heart defects and coronary anatomy.

Authors:  John B Mawson
Journal:  Tex Heart Inst J       Date:  2002

3.  Long-term outcomes after intervention for pulmonary atresia with intact ventricular septum.

Authors:  Lydia K Wright; Jessica H Knight; Amanda S Thomas; Matthew E Oster; James D St Louis; Lazaros K Kochilas
Journal:  Heart       Date:  2019-02-02       Impact factor: 5.994

4.  Regression of cardiac enzyme and ventriculocoronary communication in an infant with pulmonary atresia and intact ventricular septum after radiofrequency valvulotomy and valvuloplasty.

Authors:  M-L Lee
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

5.  Predictors of Mortality in Children with Pulmonary Atresia with Intact Ventricular Septum.

Authors:  Stephanie Grant; David Faraoni; James DiNardo; Kirsten Odegard
Journal:  Pediatr Cardiol       Date:  2017-09-04       Impact factor: 1.655

6.  Coronary Arteries in Childhood Heart Disease: Implications for Management of Young Adults.

Authors:  Fernando Baraona; Anne Marie Valente; Prashob Porayette; Francesca Romana Pluchinotta; Stephen P Sanders
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

7.  Anomalous single coronary artery on low dose MDCT.

Authors:  Anurag Yadav; T B S Buxi; Kishan Rawat; Abhishek Agarwal; Arun Mohanty
Journal:  J Radiol Case Rep       Date:  2013-05-01

8.  Isolated single coronary artery presenting as acute coronary syndrome: case report and review.

Authors:  Anil K Mahapatro; A Sarat K Patro; Vipperala Sujatha; Sudhir C Sinha
Journal:  Int J Angiol       Date:  2014-06

Review 9.  Primary noncompaction of the ventricular myocardium from the morphogenetic standpoint.

Authors:  U Bartram; J Bauer; D Schranz
Journal:  Pediatr Cardiol       Date:  2007-07-12       Impact factor: 1.838

10.  Outcomes in neonates with pulmonary atresia and intact ventricular septum underwent pulmonary valvulotomy and valvuloplasty using a flexible 2-French radiofrequency catheter.

Authors:  Meng-Luen Lee; Lon-Yen Tsao; Han-Yao Chiu; Ming Chen; Ing-Sh Chiu
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.